a b s t r a c tSeveral actin-binding proteins have been shown to be altered in metastat ic cell lines and tumours and, in particular, Myristoylated Alanine-Rich protein Kinase C substrate (MARCKS) has been implicated in the pathogenesi s of various highly metastatic epithelial malignancies. Considerin g that a large percentage of deaths due to colorectal cancer (CRC) are consequent to hepatic metastasization, aim of this study was to elucidate the involvement and mechanism of MARCKS in CRC by employing in vitro and in vivo approache s. Loss-of and-gain-on function approaches of MARCKS were employed in two human CRC cell lines: Clone A cells expressing MARCKS and LoVo cells known to have a frameshift mutation of MARCKS i.e. typically for MSI-H CRC. The data unveiled that altering MARCKS expression suppresses cell motility and invasion in human colon carcinoma cells when conditioned medium of liver-specific stromal cells (hepatic stellate cells) was used as chemoattractant. Depletion or re-expression of MAR CKS inhibited proliferati on with a reduction in expression of the mitotic regulator Aurora B kinase (AURKB), whereas AURKB -depletion did not modify MARCKS expression. In murine colon carcinoma CT26 cells, shRNA MARCKS-d epletion reduced motility and invasion, and induced an aberrant, prolonged mitotic process. Significantly less metastases were produced in a syngenei c model of colon metastasis by MARCKSdepleted CT26 in comparison to CT26-tumour challenged mice. In conclusion, MAR CKS plays an articulated role in the progression of colorectal cancer and might represent a suitable target to interfere and overcome the invasive behaviour of colon carcinoma cells at primary and distant sites.